If you are interested in learning more about this study, please call or email the contact person below
|Title||GLP-Receptor Agonist Therapy and Albuminuria in Patients with Type 2 Diabetes|
|Description||The study visits will be at Erie County Medical Center in Buffalo
If you are interested in the study please contact the coordinator below.
|Objective||The purpose of this research is to evaluate the effects of Exenatide extended release treatment for 1 year on albuminuria (protein in urine) levels in type 2 diabetes patients.
Keywords: albuminuria, type II diabetes
|Principal Investigator||DANDONA, PARESH|
|Key Eligibility||albuminuria (protein in urine)
type 2 diabetes
|Disease Group||Diabetes; Endocrine Diseases|